USEMX
Price
$30.88
Change
+$0.57 (+1.88%)
Updated
Jul 31 closing price
Net Assets
752.88M
VEMAX
Price
$48.64
Change
+$0.61 (+1.27%)
Updated
Jul 31 closing price
Net Assets
163.32B
Interact to see
Advertisement

USEMX vs VEMAX

USEMX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
USEMX vs. VEMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USEMX is a Buy and VEMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 163B vs. USEMX (753M). VEMAX pays higher dividends than USEMX: VEMAX (2.32) vs USEMX (2.08). USEMX was incepted earlier than VEMAX: USEMX (32 years) vs VEMAX (20 years). USEMX (1.51) is less costly to investors than VEMAX (0.13). USEMX is a more actively managed with annual turnover of: 84.00 vs. VEMAX (6.00). USEMX (3000) and VEMAX (3000) have matching initial minimum investment requirements. USEMX annual gain was more profitable for investors over the last year : 33.79 vs. VEMAX (19.34). USEMX return over 5 years is better than : 46.85 vs. VEMAX (27.49).
USEMXVEMAXUSEMX / VEMAX
Total Expense Ratio1.500.131,154%
Annual Report Gross Expense Ratio1.510.131,162%
Fund Existence32 years20 years-
Gain YTD22.6379.106249%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets753M163B0%
Annual Yield % from dividends2.082.3290%
Returns for 1 year33.7919.34175%
Returns for 3 years67.1646.41145%
Returns for 5 years46.8527.49170%
Returns for 10 years125.2689.08141%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDFGX30.490.46
+1.53%
BlackRock Capital Appreciation Inv A
OIEQX28.620.24
+0.85%
JPMorgan Equity Income R4
GTLOX23.840.06
+0.25%
Glenmede Disciplined US Eq Ptf
CSDGX17.130.04
+0.23%
Copeland SMID Cap Dividend Growth A
GTMUX24.78-0.03
-0.12%
Goldman Sachs Small/Mid Cap Growth R6